Takip et
Prof. Dr. Serkan Keskin
Prof. Dr. Serkan Keskin
Medikal Onkoloji Uzmanı, Memorial Şişli Hastanesi
memorial.com.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Clinical and prognostic significance of coagulation assays in lung cancer
F Tas, L Kilic, M Serilmez, S Keskin, F Sen, D Duranyildiz
Respiratory medicine 107 (3), 451-457, 2013
1172013
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
F Tas, F Sen, S Keskin, L Kilic, I Yildiz
Molecular and clinical oncology 1 (4), 788-792, 2013
672013
Noncutaneous melanoma have distinct features from each other and cutaneous melanoma
F Tas, S Keskin, A Karadeniz, N Dağoğlu, F Sen, L Kilic, I Yildiz
Oncology 81 (5-6), 353-358, 2012
672012
Obezite ve inflamasyon
S KESKİN, E SAYALI, E TEMELOĞLU, İ EKİZOĞLU
Türkiye Klinikleri Tıp Bilimleri Dergisi 25 (5), 636-641, 2005
562005
Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer
F Tas, L Kilic, E Bilgin, S Keskin, F Sen, R Ciftci, I Yildiz, V Yasasever
International Journal of Gynecologic Cancer 23 (2), 2013
472013
Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma
M Ekenel, S Keskin, M Basaran, C Ozdemir, R Meral, M Altun, I Aslan, ...
Oral oncology 47 (7), 660-664, 2011
402011
Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy
U Gezer, S Keskin, A İğci, M Tükenmez, D Tiryakioğlu, M Cetinkaya, ...
Oncology letters 8 (2), 845-848, 2014
352014
D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients
L Kilic, I Yildiz, FK Sen, MG Erdem, M Serilmez, S Keskin, R Ciftci, ...
Cancer Biomarkers 15 (4), 405-411, 2015
312015
Mucosal melanoma in the head and neck region: different clinical features and same outcome to cutaneous melanoma
F Tas, S Keskin
International Scholarly Research Notices 2013, 2013
292013
Current adjuvant treatment modalities for gastric cancer: from history to the future
L Kilic, C Ordu, I Yildiz, F Sen, S Keskin, R Ciftci, KN Pilanci
World journal of gastrointestinal oncology 8 (5), 439, 2016
282016
High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer
R Ciftci, F Tas, CT Yasasever, E Aksit, S Karabulut, F Sen, S Keskin, ...
Tumor Biology 35, 6941-6948, 2014
282014
Türkiye’de meme kanserli hastaların tanı ve tedavi yöntemlerine ulaşım hızı; çok merkezli gözlemsel çalışma
P Saip, S Keskin, M Özkan, MA Kaplan, F Aydoğan, GG Demirağ, ...
The Journal of Breast Health 7 (3), 109-117, 2011
272011
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
N Faruk Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, ...
Medical Oncology 30, 1-6, 2013
262013
Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy
S Keskin, M Muslumanoglu, P Saip, H Karanlık, M Guveli, E Pehlivan, ...
Oncology 81 (1), 30-38, 2011
252011
The major stressful life events and cancer: stress history and cancer
F Tas, U Karalar, M Aliustaoglu, S Keskin, G Can, FE Cinar
Medical Oncology 29, 1371-1377, 2012
242012
Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis
ZG Ozkan, A Poyanli, A Ucar, S Kuyumcu, F Akyuz, S Keskin, S Saglam, ...
Cancer Biotherapy and Radiopharmaceuticals 30 (3), 132-138, 2015
232015
Clinical and prognostic significance of coagulation assays in melanoma
F Tas, R Ciftci, L Kilic, E Bilgin, S Keskin, F Sen, I Yildiz, V Yasasever
Melanoma research 22 (5), 368-375, 2012
202012
Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with …
Y Eralp, S Keskin, E Akisik, E Akisik, A Igci, M Müslümanoglu, S Yilmaz, ...
American journal of clinical oncology 36 (3), 215-223, 2013
182013
Clinicopathological characteristics and treatment outcomes of adult patients with paratesticular rhabdomyosarcoma (PRMS): A 10-year single-centre experience
S Keskin, M Ekenel, M Basaran, I Kilicaslan, M Tunc, S Bavbek
Canadian Urological Association Journal 6 (1), 42, 2012
182012
Fama-French çok faktör varlık fiyatlama modellerinin performanslarının karşılaştırılması: Borsa İstanbul üzerine bir uygulama
A Güler, ÇAM İlhan, B Zavalsiz, S Keskin
Istanbul business research 47 (2), 183-207, 2018
172018
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20